Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-4449
Bioorg Med Chem 2003 Nov 17;1123:4891-6. doi: 10.1016/j.bmc.2003.09.016.
Show Gene links Show Anatomy links

Aza-THIP and related analogues of THIP as GABA C antagonists.

Krehan D , Frølund B , Ebert B , Nielsen B , Krogsgaard-Larsen P , Johnston GA , Chebib M .


???displayArticle.abstract???
The potency of a series of eight compounds structurally related with 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP), a potent GABA(A) partial agonist exhibiting GABA(C) rho(1) antagonist effect (K(i)=25 microM), was determined electrophysiologically using homomeric human GABA(C) rho(1) receptors expressed in Xenopus oocytes. Protolytic properties (pK(a) values for the acidic bioisosteric groups) and the presence of steric bulk in the molecules appear to be structural parameters of importance for blockade of the GABA(C) rho(1) receptor. Within this series of moderately potent GABA(C) antagonists, only 4,5,6,7-tetrahydropyrazolo[5,4-c]pyridin-3-ol (Aza-THIP) does not interact detectably with GABA(A) receptors, and Aza-THIP has the potential of being a useful tool for molecular and behavioural pharmacological studies.

???displayArticle.pubmedLink??? 14604650
???displayArticle.link??? Bioorg Med Chem